文献速递心力衰竭与心肌病高血压

弗雷明汉研究:心力衰竭的终生风险五十年间上升

Lifetime Risk of Heart Failure Among Participants in the Framingham Study.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

该研究基于弗雷明汉研究两个25年时期(1965-1989和1990-2014),比较50岁时心力衰竭的残余终生风险。结果显示女性风险从18.86%升至22.55%,男性从19.19%升至25.25%,心衰发病平均年龄延后6.6至7.2年,可能与预期寿命增加有关。

要点

  • 女性50岁时心衰终生风险从18.86%升至22.55%,男性从19.19%升至25.25%。
  • 心衰发病平均年龄在两个时期之间延后6.6年(女)至7.2年(男)。
  • 超重/肥胖、高血压及无心肌梗死史者中心衰终生风险增幅一致。

核心结论

  • 在弗雷明汉研究的白人社区样本中,过去五十年50岁时心衰的残余终生风险上升,可能与预期寿命增加有关。

研究设计与样本

  • 基于弗雷明汉研究的社区队列分析,比较1965-1989和1990-2014两个25年时期50岁时心衰的残余终生风险,并校正死亡竞争风险。
  • 第一时期共111,351人年观察发生624例心衰事件,第二时期共128,903人年观察发生875例心衰事件。

主要发现

  • 女性平均预期寿命从75.9岁增至82.1岁,男性从72.5岁增至78.1岁。
  • 女性50岁时心衰残余终生风险从18.86%升至22.55%,绝对增加3.69%(95%CI 0.90-6.49,P=0.01)。
  • 男性50岁时心衰残余终生风险从19.19%升至25.25%,绝对增加6.06%(95%CI 3.08-9.04,P<0.001)。
  • 心衰发病平均年龄在两个时期之间增加6.6年(女性)至7.2年(男性)。
  • 在超重/肥胖、血压较高及无心肌梗死史的参与者中,第二时期心衰终生风险相对增加28%-47%和23%。

临床怎么用

  • 临床医生应认识到心衰终生风险在上升,即使发病年龄延后,一级预防仍需加强。
  • 对超重/肥胖、高血压及无心肌梗死史者,应关注心衰终生风险增加的趋势。

局限性

  • 研究基于白人社区样本,结果外推至其他种族人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The residual lifetime risk (RLR) of developing heart failure (HF) may have changed over time because of the increasing population burden of hypertension, obesity, and diabetes; greater survival after myocardial infarction; and a greater lifespan. OBJECTIVES: The authors assessed changes in the RLR for HF in two 25-year epochs (1965-1989 and 1990-2014). METHODS: We compared the RLR of HF at age 50 years (adjusting for competing risk of death) in the 2 epochs in Framingham Study participants overall and in the following strata: sex, body mass index, blood pressure, and diabetes. RESULTS: Mean life expectancy increased from 75.9 to 82.1 years in women and 72.5 to 78.1 years in men. We observed 624 HF events over 111,351 person-observations in epoch 1, and 875 HF events over 128,903 person-observations in epoch 2. The mean age at onset of HF increased across the epochs by 6.6 years (women) to 7.2 years (men). The RLR of HF at age 50 years increased across epochs from 18.86% to 22.55% (absolute increase 3.69; 95% CI: 0.90-6.49; P = 0.01) in women, and from 19.19% to 25.25% (absolute increase 6.06; 95% CI: 3.08-9.04; P < 0.001) in men. The increase in RLR of HF in the second epoch was consistent across strata with excess body mass index or higher blood pressure (relative increase of 28%-47%) and in participants without prior myocardial infarction (relative increase of 23%). CONCLUSIONS: The RLR of HF has increased in our community-based sample of White individuals over the last 5 decades, possibly caused by an increase in life expectancy.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Vasan, Enserro, Beiser, et al. Lifetime Risk of Heart Failure Among Participants in the Framingham Study. J Am Coll Cardiol. 2022. PMID: 35057911. doi:10.1016/j.jacc.2021.10.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。